ARCHIVES

Palmetto Establishes Coverage For Thyroid Genomic Test

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

April 25, 2014

Two-Drug Combination Extends Survival Of Mesothelioma

May 31, 2002

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

Seattle Times, The Hutch Duel Over Five-Part Series.

March 23, 2001

AACI Says Fund Reductions Hurt Cancer Centers

March 24, 1978

NCI “Community Cancer Centers” Program in Development, House Report Reveals.

June 30, 2006